Literature DB >> 31422759

Changes in carotid artery structure with smoking cessation.

Carol Mitchell1, Megan E Piper2, Stevens S Smith2, Claudia E Korcarz1, Michael C Fiore2, Timothy B Baker2, James H Stein1.   

Abstract

Carotid artery grayscale ultrasound echogenicity and texture features predict cardiovascular disease events. We evaluated the longitudinal effects of smoking cessation on four grayscale ultrasound measures. This was a secondary analysis of data from 188 age, sex, and body mass index (BMI)-matched smokers (94 eventual abstainers [EA], 94 continued smokers [CS]) from a smoking cessation trial that had carotid ultrasound examinations at baseline and after 3 years. General linear models that included time, smoking group (EA or CS), and a time*smoking interaction term were used to examine the impact of smoking abstinence on carotid artery grayscale marker values at year 3. Participants were mean (SD) 50.3 (11.4) years old (57% female, 86% white). The baseline grayscale median value (GSM) was inversely correlated with age, BMI, insulin resistance, and smoking pack-years (r = -0.20 to -0.30, p < 0.007 for all). There was a significant time*smoking status interaction for predicting GSM at year 3: GSM decreased significantly in the EA group compared to the CS group (-3.63 [13.00] vs CS 0.39 [12.06] units; p = 0.029). BMI increased more in the EA than the CS group (2.42 [3.00] vs CS 0.35 [2.57] kg/m2; p < 0.001). After adjusting for changes in BMI, the time*smoking status interaction no longer was significant (p = 0.138). From baseline to year 3, contrast increased similarly in both groups. Entropy and angular second moment did not change significantly in either group. Changes in carotid ultrasound echogenicity and grayscale texture features during a smoking cessation attempt are modest and mostly related to weight gain. Clinicaltrials.gov Identifier: NCT01553084.

Entities:  

Keywords:  carotid ultrasound; grayscale; grayscale median (GSM); smoking; vascular imaging

Mesh:

Year:  2019        PMID: 31422759      PMCID: PMC7552918          DOI: 10.1177/1358863X19867762

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  31 in total

1.  Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate.

Authors:  James H Stein; Eunice Yeh; Joanne M Weber; Claudia Korcarz; Paul M Ridker; Ahmed Tawakol; Priscilla Y Hsue; Judith S Currier; Heather Ribaudo; Carol K C Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

2.  Carotid artery ultrasound texture, cardiovascular risk factors, and subclinical arterial disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carol C Mitchell; Claudia E Korcarz; Matthew C Tattersall; Adam D Gepner; Rebekah L Young; Wendy S Post; Joel D Kaufman; Robyn L McClelland; James H Stein
Journal:  Br J Radiol       Date:  2018-01-31       Impact factor: 3.039

3.  Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of experimental myocardial contusion.

Authors:  D J Skorton; S M Collins; J Nichols; N G Pandian; J A Bean; R E Kerber
Journal:  Circulation       Date:  1983-07       Impact factor: 29.690

4.  Ultrasound carotid plaque features, cardiovascular disease risk factors and events: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Carol Mitchell; Claudia E Korcarz; Adam D Gepner; Joel D Kaufman; Wendy Post; Russell Tracy; Amanda J Gassett; Nanxun Ma; Robyn L McClelland; James H Stein
Journal:  Atherosclerosis       Date:  2018-06-12       Impact factor: 5.162

5.  Echogenicity of the carotid arterial wall in active smokers.

Authors:  Carol Mitchell; Megan E Piper; Claudia E Korcarz; Kristin Hansen; JoAnne Weber; Michael C Fiore; Timothy B Baker; James H Stein
Journal:  J Diagn Med Sonogr       Date:  2017-12-19

6.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

7.  Brachial artery intima-media thickness and grayscale texture changes in patients with peripheral artery disease receiving supervised exercise training in the PROPEL randomized clinical trial.

Authors:  Jack Berroug; Claudia E Korcarz; Carol Kc Mitchell; JoAnne M Weber; Lu Tian; Mary M McDermott; James H Stein
Journal:  Vasc Med       Date:  2018-11-12       Impact factor: 3.239

8.  Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial.

Authors:  Heather M Johnson; Megan E Piper; Timothy B Baker; Michael C Fiore; James H Stein
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Association between Weight Changes after Smoking Cessation and Cardiovascular Disease among the Korean Population.

Authors:  Eun Ha Kim; Hyejin Lee; Dong Wook Shin; Jae Moon Yun; Jung-Hyun Shin; Yoo Kyoung Lim; Hye Yeon Koo; Miso Jang
Journal:  Korean J Fam Med       Date:  2017-05-23

10.  Carotid Artery Echolucency, Texture Features, and Incident Cardiovascular Disease Events: The MESA Study.

Authors:  Carol C Mitchell; Claudia E Korcarz; Adam D Gepner; Rebecca Nye; Rebekah L Young; Mika Matsuzaki; Wendy S Post; Joel D Kaufman; Robyn L McClelland; James H Stein
Journal:  J Am Heart Assoc       Date:  2019-02-05       Impact factor: 5.501

View more
  2 in total

1.  Diagnostic significance of transcranial doppler combined with carotid ultrasound in patients with cerebral ischemic stroke.

Authors:  Huijun Wang; Li Fei; Hongbo Xia; Qian Zhang; Youping Huang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Longitudinal effects of smoking cessation on carotid artery atherosclerosis in contemporary smokers: The Wisconsin Smokers Health Study.

Authors:  James H Stein; Stevens S Smith; Kristin M Hansen; Claudia E Korcarz; Megan E Piper; Michael C Fiore; Timothy B Baker
Journal:  Atherosclerosis       Date:  2020-11-15       Impact factor: 5.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.